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Abstract
Background: Aggresomes are pericentrosomal accumulations of misfolded proteins, chaperones
and proteasomes. Their positioning near the centrosome, like that of other organelles, requires
active, microtubule-dependent transport. Linker proteins that can associate with the motor
protein dynein, organelles, and microtubules are thought to contribute to the active maintenance
of the juxtanuclear localization of many membrane bound organelles and aggresomes. Hook
proteins have been proposed to serve as adaptors for the association of cargos with dynein for
transport on microtubules. Hook2 was shown to localize to the centrosome, bind centriolin, and
contribute to centrosomal function.
Results: Here we show that overexpression of hook2 promotes the accumulation of the cystic
fibrosis transmembrane regulator in aggresomes without altering its biochemical properties or its
steady state level. A dominant negatively acting form of hook2 that lacks the centriolin binding C-
terminal inhibits aggresome formation.
Conclusion: We propose that hook2 contributes to the establishment and maintenance of the
pericentrosomal localization of aggresomes by promoting the microtubule-based delivery of
protein aggregates to pericentriolar aggresomes.
Background
Intracellular protein aggregates form when misfolded pro-
teins accumulate in cells because of malfunctioning or
overloading of either the quality control pathways that
recognize and route defective proteins for degradation or
the elements of the actual degradative pathway [1]. Aggre-
gates distribute randomly throughout the cell and can be
associated with pathogenic changes; for example, they
may block microtubule-based transport [2] or sequester
components of the ubiquitin-proteasome system [3].
One of the cellular responses to potentially pathogenic
aggregates of misfolded proteins is their dynein-mediated
retrograde transport along microtubules to the centro-
some [4,10] where they are enriched together with ele-
ments of the protein-folding and degradation machinery
in pericentriolar structures, called aggresomes [4-9].
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Aggresomes may protect cells by sequestering harmful
protein aggregates and enhancing their degradation either
by concentrating them together with proteasome subunits
or by triggering their uptake into autophagosomes and
delivery to lysosomes [10]. Experimentally induced aggre-
somes stirred general interest, because they are similar in
composition and morphology to inclusion bodies found
in brains of patients who died of neurodegenerative dis-
eases [6,7,9,11].
The most studied protein that accumulates in aggresomes
is the cystic fibrosis transmembrane regulator (CFTR).
Similar to some other integral membrane proteins that
have large hydrophobic regions [12], over-expressed CFTR
is inefficiently processed [13]. This is even more pro-
nounced for a prevalent mutation in cystic fibrosis
patients, the ∆F508-CFTR deletion mutant, which is
degraded by the proteasome [14,15]. When the degrada-
tion of CFTR is inhibited, CFTR accumulates in pericen-
trosomal aggresomes [7,9]. The retrograde transport of
CFTR and other misfolded proteins depends on the integ-
rity of the microtubule cytoskeleton and the association of
dynein with the cargo-binding dynactin complex
[4,16,17].
Linker proteins that associate with dynein, organelles, and
microtubules facilitate the loading of cargos for retrograde
transport and contribute to the establishment and active
maintenance of the juxtanuclear localization of organelles
[18], and thus they may play a role in the formation of
aggresomes. Hook-related proteins were proposed to
function as linker proteins [19]. Hook proteins are com-
posed of a conserved N-terminal domain, a central coiled-
coil, and a more divergent C-terminal domain that has
been implicated in the binding of each of the hook pro-
teins to a different class of organelles [20,21].
Data from several studies suggested that hook proteins
may modulate microtubule based transport. The first
identified member of the hook family, Drosophila hook,
was originally discovered based on a defect in endocytic
trafficking [22,23]. The characterization of a C. elegans
homolog, zyg-2, revealed a function in binding and link-
ing centrosomes to nuclei through the microtubule
cytoskeleton [24]. We recently found that mammalian
hook2 also localizes to centrosomes, in this case through
a direct interaction with centriolin [21]. In addition, alter-
ing hook2 levels or function led to the accumulation of
both endogenous and overexpressed proteins at the cen-
trosome, raising the possibility that hook2 may influence
aggresome formation.
Here, we are using mutant CFTR, which is well-known to
accumulate in aggresomes [7,9], to examine whether
hook2 contributed to the accumulation of misfolded pro-
teins around the centrosome. We found that altering
hook2 activity by overexpressing hook2 or using domi-
nant-negative hook2 proteins changed the distribution of
aggresome constituents. We have considered the possibil-
ity that hook2 induced changes in the activities of the pro-
tein degradation pathway, such as ubiquitination,
however we found no evidence for hook2-induced bio-
chemical changes in CFTR. Therefore, we propose a model
wherein hook2 influences aggresome formation by inter-
fering with the functioning of the centrosome in the coor-
dination of vectorial intracellular transport.
Results
Hook2 co-localizes with aggresomes at the centrosome
Endogenous and overexpressed hook2 localizes to the
centrosome, as we previously showed by colocalization
with the centrosomal markers ninein and gamma-tubu-
lin, at the center of the radial microtubule array [21]. The
juxtanuclear localization of over-expressed hook2-con-
structs resembled the centrosomal distribution of endog-
enous hook2 in an accentuated form [Fig. 1A and ref.
[21]]. Centrosomal accumulation of hook2 gradually
increased upon continued expression over 3 days with
only a modest change in the number of cells with centro-
somally localized hook2 (Fig. 1B). We have previously
shown that centrosomal accumulation of hook2 did not
disrupt the microtubule network or the Golgi complex
[21], indicating that hook2 overexpression did not disrupt
the structural integrity of cells.
Because overexpressed hook2 accumulated around the
centrosome, we wondered whether hook2 and compo-
nents of aggresomes co-localized. To induce aggresomes
experimentally, the proteasome inhibitor lactacystin [26]
was applied to cells that co-expressed ∆F508-CFTR and
hook2. After 12 h of lactacystin treatment, aggregates of
CFTR co-localized with hook2 in juxtanuclear aggresomes
(Fig. 1C–E).
Over-expressed hook2 promotes the juxtanuclear 
accumulation of aggresome components
Hook2 not only co-localized with lactacystin-induced and
CFTR-containing aggresomes, but also induced aggre-
some formation in the absence of proteasome inhibitors
and CFTR, as indicated by the juxtanuclear accumulation
of endogenous hsc70, ubiquitin, and the 20S component
of the proteasome in hook2 transfected cells (Fig. 1F–H).
Dynein-mediated transport of cargo to aggresomes is nec-
essary for their formation, but in this process the dynein
motor also becomes concentrated within aggresomes
[4,16]. Consistent with these results, we observed that
aggresomes induced by hook2 were enriched in dynein,
even in the absence of lactacystin. This accumulation was
visible already at the earliest stages in hook2-inducedBMC Cell Biology 2007, 8:19 http://www.biomedcentral.com/1471-2121/8/19
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aggresome formation when little hook2 had accumulated
(Fig 1I) and became more pronounced as the amount of
centrosomal hook2 accumulation increased (Fig 1J).
Moderately overexpressed CFTR is found throughout the
secretory system including the ER and on the plasma
membrane (Fig. 2A "diffuse"). With increased expression
or upon addition of proteasome inhibitors, misfolded
CFTR forms multiple aggregates that tend to localize close
to the nucleus but are found throughout the cell (Fig. 2A
"aggregated") and over time concentrates in compact jux-
tanuclear aggresomes (Fig. 2A "aggresome"). Time lapse
imaging has previously captured these three types of dis-
tributions as stages along the pathway of aggresome for-
mation [4]. After 6 hrs of lactacystin treatment, CFTR is
found in aggregates in 70% of cells, but only in 14% of
these it has accumulated yet in a single prominent aggre-
some (Fig. 2B). While the percentage of cells with aggre-
gates modestly increased to 84% after 12hrs, the incidence
of aggresomes more than doubled to 34%.
Co-expression with hook2 caused a dramatic increase in
the frequency of ∆F508-CFTR aggresomes at each time
point. The hook2-induced increase of CFTR in aggresomes
was most obvious without treatment with lactacystin
(from 2% to 22%, n > 1000; Fig. 2B, 0 h). Hook2 coex-
pression did not result in an increase in the percentage of
cells with aggregated CFTR after 6 or 12 hrs in the presence
of lactacystin. However, at every time point, the frequency
of aggresomes at least doubled upon hook2 coexpression.
The effect of hook2 on the induction of aggresomes with-
out lactacystin treatment was even more pronounced
when the distribution of ∆F508-CFTR was considered sep-
arately in cells with hook2 accumulation at the centro-
some and in cells with diffuse hook2: 54% of cells with
centrosomal hook2 had ∆F508-CFTR-positive aggresomes
compared to only 3% of cells with a diffuse hook2 distri-
bution (Fig. 2C). Therefore, centrosomally localized
hook2 promotes aggresome formation.
We also examined the effect of CFTR co-expression on the
distribution of hook2. If the effect of hook2 on CFTR
accumulation in aggresomes is only due to an unspecific
increase in the level of misfolded proteins, then misfolded
CFTR should have a reciprocal effect on hook2. However,
in contrast to the dramatic effect of hook2 on ∆F508-
CFTR localization, ∆F508-CFTR had no effect on hook2
localization. Hook2 juxtanuclear aggregates were seen in
the same percentage of cells with and without ∆F508-
CFTR (Fig. 2D). Inhibition of proteasome activity
increased the number of cells with juxtanuclear hook2
accumulation, but ∆F508-CFTR had no effect on hook2
distribution. Moreover, 100% of ∆F508-CFTR aggresomes
were also enriched in hook2. By contrast, only 29% of the
Hook2 co-localizes with aggresomes at the centrosome and  promotes aggresome formation Figure 1
Hook2 co-localizes with aggresomes at the centro-
some and promotes aggresome formation. Vero cells 
were transfected to express Hook2. (A) Immunostaining 
revealed Hook2 either diffusely distributed (type I) or 
enriched at centrosomes (types II-IV) and [21]. Type IV 
refers to large aggresomes (> 4 µm). (B) Cells containing dis-
tinct Hook2 patterns were counted after the indicated days 
of expression. The fraction of cells with some hook2 at cen-
trosomes (type II-IV combined) only modestly increased 
from 1 to 3 days of expression. The fraction of cells in which 
co-expressed CFTR accumulated in large juxtanuclear aggre-
somes (type IV) increased about ten-fold from day 1 to 3. (C-
D) Cells were transfected to express hook2 and ∆F508-
CFTR or (E) hook2 and CFTR-GFP. After 24 hours, 10 µM 
lactacystin was added and cells were incubated for an addi-
tional 16 hours before either being double-stained (C-D) for 
hook2 (red in merged images) and co-expressed CFTR 
(green) or triple stained (E) for hook2, CFTR and endog-
enous hsc70. (F-J) Hook2 was expressed in the absence of 
CFTR and lactacystin and tested for co-localization with the 
endogenous aggresome markers hsc-70, ubiquitin (FK1), the 
20S proteasome subunit or cytoplasmic dynein, as indicated. 
Merged images in (I and J) indicate the accumulation of 
dynein in hook2-induced type II (I) and type IV (J) aggre-
somes.BMC Cell Biology 2007, 8:19 http://www.biomedcentral.com/1471-2121/8/19
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cells with diffusely distributed ∆F508-CFTR contained
hook2-positive type IV aggresomes (Fig. 2E). The finding
that hook2 distribution at the centrosome is not influ-
enced by the level of misfolded and aggregated ∆F508-
CFTR argues against hook2 simply accumulating in aggre-
somes as misfolded proteins. Taken together, these date
indicate that centrosomally located hook2 promotes
aggresome formation.
Interference with hook2 function alters CFTR aggresome 
formation
To further test a possible role for hook2 in aggresome for-
mation, we attempted different approaches to interfere
with hook2 function. Because so far we have not been suc-
cessful in significantly knocking down hook2 levels by
RNAi, we expressed hook2 truncations that are predicted
to act as dominant negatives. This approach has previ-
ously been successful in Drosophila where phenotypes very
similar to those of the hook11 null allele resulted from the
expression of dHook proteins that were truncated at their
N- or C-termini but retained the coiled-coil dimerization
domain [22].
Thus, we tested whether corresponding hook2 truncation
mutants altered aggresome formation. We counted the
number of cells with distinct CFTR distributions in Vero
cells (Figure 3A) or HEK293 cells (data not shown) that
expressed ∆F508-CFTR for 48 hours together with various
hook2 constructs. Especially ∆C-hook2, which lacks the
centriolin binding site of hook2 [21], but retains its
dimerization domain, was expected to interfere with the
function of the endogenous hook2 protein.
In the absence of lactacystin, CFTR distribution was
mildly altered by co-expression of ∆C-hook2: it reduced
the fraction of cells with CFTR aggresomes to 1% from 3%
observed with CFTR alone, and increased the fraction of
cells with aggregated CFTR from 5% to 9%. By contrast,
under these conditions co-expression of full-length hook2
increased the fraction of cells with CFTR in aggresomes
from 3% to 24%. This effect is specific, as co-expression of
hook3 or the hook chimeras 332 and 233, which contain
mostly hook3 sequences, did not increase CFTR aggrega-
tion.
The presence of lactacystin (Figure 3B) caused a large
increase in the percentage of cells with CFTR aggregates
and aggresomes [7,9]. However, even under these condi-
tions hook2 proteins retained their effect on aggresome
formation. Compared to CFTR-only transfected cells,
cotransfection with wild-type hook2 doubled the fraction
of cells with aggresomes and made them as frequent as
cells with aggregates. By contrast, the presence of the dom-
inant negative ∆C-hook2 caused a reduction in the per-
centage of cells with perinuclear aggregates and
Effects of hook2 on aggresomes formation Figure 2
Effects of hook2 on aggresomes formation. (A) Vero 
cells were transfected to express CFTR. Immunofluores-
cence staining revealed CFTR either diffusely distributed , 
aggregated  , or accumulated in aggresomes ■ . (B-C) Cells 
were transfected to express ∆F508-CFTR with or without 
hook2. After 24 h 10 µM lactacystine was added for the indi-
cated times, before cells were stained for CFTR and the frac-
tions of cells exhibiting distinct patterns were counted. Pie 
charts show an increase in the percentage of cells with aggre-
somal CFTR in cells that co-express hook2, compared to 
cells that express ∆F508-CFTR alone. Even though lactacys-
tin treatment increased the incidence of ∆F508-CFTR in 
aggresomes, hook2 promoted aggresome formation in the 
absence of lactacystin (0 h). (C) The aggresome-promoting 
effect of hook2 was even more pronounced when cells in 
which hook2 was enriched at centrosomes were considered 
separately from those in which hook2 was distributed dif-
fusely. (D-E) Cells were transfected to express hook2 alone 
or with ∆F508-CFTR and the fraction of cells with type IV 
hook2 distribution (See Fig. 1A) was counted. (D) In contrast 
to the effect of hook2 on CFTR (shown in B and C), the 
presence of CFTR did not change the percentage of cells 
with type IV hook2. 6 or 12 hours of lactacystin exposure 
increased the percentage of cells with hook2 aggresomes, 
but CFTR had no additional effect. (E) CFTR distribution 
strongly correlated with that of hook2 since in 100% of cells 
with aggresomal CFTR hook2 was co-enriched at centro-
somes.
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aggresomes consistent with hook2 playing a role in their
formation.
N-terminally truncated hook2 had an effect similar to that
of ∆C-hook2. In the presence of lactacystin, co-expression
of ∆N-hook2 reduced by ~50% the percentage of cells
with ∆F508-CFTR in aggresomes compared to CFTR-only
transfected cells. Similar results were obtained in five sep-
arate experiments in VERO cells (Figure 3B) as well as
HEK293 cells (data not shown). The interpretation of
these results is complicated by our previous finding that
∆N-hook2 can recruit centrosomal proteins such as
ninein and thus may indirectly interfere with retrograde
transport [21]. Importantly, no inhibitory effect on aggre-
some formation was observed upon co-expression of
hook3 (Fig. 3B). On the contrary, hook3 over-expression
enhanced the effect of lactacystin and caused a further
increase in aggresomes; this is likely due to an unspecific
effect, since Hook3 itself accumulates at centrosomes
when proteasome activity is inhibited (data not shown).
Consistent with this notion, co-expression of C-terminally
truncated hook3 or hook1 did not result in a reduction in
aggresomes (data not shown), further supporting a spe-
cific function for hook2 in aggresome formation.
In an attempt to pinpoint a specific domain in hook2
responsible for its effect on aggresome formation, we
tested several chimeras between hook2 and hook3. We
found that chimeras of hook2 and the C- or the N-termi-
nus of hook3 enhanced aggresome formation in the
absence of lactacystin (Fig. 3A). Interestingly, this paral-
lels our previous findings with these chimeras showing
that domains partially redundant between hook2 and
hook3 contribute to centrosomal localization of hook2
[21].
Hook2 changes CFTR distribution without an obvious 
biochemical change
Expression of hook2 could affect aggresome formation by
altering biochemical properties of CFTR that cause it to
aggregate or by changing the degree to which aggregated
CFTR is transported to aggresomes. To distinguish
between these possibilities, first we investigated whether
hook2 coexpression changed the biochemical properties
of CFTR.
Lactacystin induced a shift to an insoluble high-molecular
weight ubiquitinated form of ∆F508-CFTR [Figure 4A–B
and [14,15]]. Extraction of cells also indicated that the
accumulating high molecular form of CFTR was insoluble
in 1% TritonX-100 and a small fraction was insoluble
even in 1% SDS (Fig. 4C). Hook2 co-expression in the
absence of lactacystin did not significantly change either
the electrophoretic mobility pattern of CFTR (Fig. 4D) or
its solubility (Fig. 4E), suggesting that effects of hook2 on
CFTR distribution are more likely due to an alteration in
the transport of CFTR aggregates to aggresomes.
In addition, we also explored whether co-expression of
hook2 truncations modified CFTR. Immunoblots of Tri-
ton X-100 extracts from cells co-expressing ∆F508-CFTR
and either ∆N-hook2 or ∆C-hook2 showed that these
dominant-negative constructs did not alter the electro-
phoretic mobility pattern of ∆F508-CFTR or its solubility,
whether lactacystin was present or not (Fig. 5A). Further-
more, we speculated that changes in aggresome formation
might be due to an inhibition of proteasome-mediated
degradation of CFTR by over-expressed hook proteins.
Therefore we compared levels of wild-type CFTR or
∆F508-CFTR proteins after co-transfection with hook2 or
hook truncation mutants and various controls in the
absence of lactacystin (Fig. 5B). Equivalent loading was
assured by loading 20 µg total protein per lane. No change
in steady-state CFTR protein levels was observed. These
results indicated that the effect of hook2 truncation pro-
teins on the subcellular distribution of ∆F508-CFTR was
not due to changes in its biochemical properties or a
change in proteasome activity.
Discussion
Hook proteins constitute a family of coiled-coil proteins
that have been implicated in the positioning of a variety
of organelles [27]. In this study we present experiments
Effect of hook proteins on CFTR distribution Figure 3
Effect of hook proteins on CFTR distribution. Hook 
proteins and CFTR were co-expressed in Vero cells for 36 
hours in the absence (A) or presence (B) of 10 µM lactacys-
tin for the final 12 hours. Graphs show the fraction of cells 
with aggregated CFTR (top) or with CFTR in juxtanuclear 
aggresomes (bottom), as shown in Figure 2A. In the rest of 
cells, CFTR was distributed diffusely throughout the cell. At 
least 400 cells were counted for each construct in at least 
two separate assays. For hook2 and hook2 truncations more 
than 5000 cells from at least ten separate assays were 
counted and yielded similar results. Results shown are from 
one representative experiment in which all constructs were 
used in parallel. While absolute numbers changed significantly 
in different experiments, the relative effect of different con-
structs was highly consistent between different experiments.
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suggesting that hook2 may function in the positioning or
formation of aggresomes, pericentriolar accumulations of
misfolded proteins, proteasomes and chaperones. Hook2
expression enhanced the recruitment of aggresome com-
ponents to the centrosome, in addition to the molecular
motor dynein which previously had been shown to accu-
mulate in aggresomes and is necessary for their formation
[4,16]. Furthermore, the accumulation of CFTR into
aggresomes was inhibited by a hook2 C-terminal trunca-
tion that is modelled after a dominant-negative form of
the Drosophila hook protein [23] and lacks the centriolin
binding region of hook2 [21]. Expression of truncation
mutants or full-length hook2 also altered the distribution
of the centrosomal proteins PCM-1 and ninein [21], indi-
cating that the effect of hook2 on aggresome formation
may result from its primary role in regulating the activities
of the centrosome.
A first clue to a possible function of hook2 in aggresome
formation comes from its subcellular localization at the
Dominant-negative hook2 proteins do not alter the bio- chemical properties of CFTR Figure 5
Dominant-negative hook2 proteins do not alter the 
biochemical properties of CFTR. (A) Western blots 
indicate that co-expression of hook2 truncations did not sig-
nificantly change the ratio of CFTR in the high (**) to low-
molecular mass (*) bands or the detergent solubility of 
∆F508-CFTR. (B) Western blots of homogenates of cells co-
transfected with CFTR and various hook proteins or con-
trols showed that steady state levels of wt CFTR or ∆F508-
CFTR were not altered by the indicated hook proteins. Band 
C is the mature CFTR protein and band B the core glyco-
sylated form [41]. Equivalent loading was assured by evalua-
tion of protein concentrations in cell lysates using the DC 
Protein Assay from BioRad. 20 µg total protein was loaded 
per well.
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Hook2 expression has no effect on the biochemical proper- ties of CFTR Figure 4
Hook2 expression has no effect on the biochemical 
properties of CFTR. (A) Vero cells transfected with 
∆F508-CFTR were treated (+) or not (-) with lactacystin 
(lact), lysed and immunoblotted (blot:) for CFTR (left) and 
ubiquitin (middle). Stars indicate bands specifically seen in 
∆F508-CFTR-expressing cells, compared to untransfected 
controls (-). As shown previously [39, 40] the upper band of 
CFTR runs at the same position as the ubiquitin-rich band in 
∆F508-CFTR transfected and lactacystin treated cells. To 
control for loading membranes were stained with MemCode 
after immunoblotting (right). (B) Anti-ubiquitin antibodies 
also recognized the upper band of immunoprecipitated 
CFTR. (C) CFTR was expressed in the presence of lactacys-
tin and analyzed by differential detergent extraction. Little 
CFTR was extracted by 1% Triton X-100 (1). Whereas the 
lower band of CFTR is soluble in 1% SDS (ISS), a fraction of 
the upper band is detected in the pellet of the 1% SDS 
extract (ISP) and needed to be solubilized in 6% SDS, as pre-
viously observed for other proteins in aggresomes [4, 14]. 
(D) CFTR western blot of whole cell homogenates of 
untransfected cells (lane 1) or cells expressing ∆F508-CFTR-
GFP alone (lane 2) or together with hook2 (lanes 3 and 4 are 
duplicates) showed that hook2 had no effect on the migra-
tion of ∆F508-CFTR in SDS-PAGE gels. The apparent 
reduced level of CFTR-GFP after hook2 co-expression was 
not consistently observed. (E) Hook2 co-expression did not 
significantly change the fraction of ∆F508-CFTR detected in 
Western blots of the 0.1% or 1% Triton-X 100 soluble or 
insoluble (IS) fractions.
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centrosome. Pericentrosomal accumulation in aggre-
somes has been observed for many overexpressed proteins
[10], but several of our findings argue for hook2 playing a
more active role than just being a misfolded substrate for
aggresome formation. Importantly, centrosomal localiza-
tion did not depend on overexpression-induced misfold-
ing, but was also observed for endogenous hook2 [21]. In
addition, dominant-negative hook2 proteins reduced the
accumulation of co-expressed ∆F508-CFTR in aggresomes
whereas wild-type hook2 enhanced it. This is unlikely to
be due to the co-aggregation of misfolded hook2 and
CFTR proteins, because aggregation is a specific process;
even if two misfolded proteins are co-expressed they accu-
mulate in separate aggregates [8].
A mechanism by which hook2 might enhance the forma-
tion of CFTR containing aggresomes is through the inhibi-
tion of proteasome activity by overexpressed hook2, as
had been observed for some misfolded proteins [3,28].
However, for hook2, we do not consider this as a likely
explanation for the following reasons: First, even when
proteasome activity was inhibited by lactacystin, hook2
further enhanced aggresome formation compared to lac-
tacystin on its own (Fig. 2), indicating that hook2 acts
through a mechanism distinct from proteasome inhibi-
tion. Second, overexpressed C- and N-terminal trunca-
tions of hook2 which would be more likely to be
misfolded than the wild-type protein and thus expected to
promote aggresome formation, actually had the opposite
effect and inhibited aggresome formation (Fig. 3). Third,
whereas inhibition of proteasome activity resulted in a
shift to a ubiquitinated high-molecular form and
increased levels of CFTR [Fig. 4 and refs. [14,15]], no such
changes were observed for ∆F508-CFTR after co-expres-
sion with wild-type or mutant forms of hook2 (Figs. 4, 5).
Forth, if hook2 enhanced CFTR aggresomes by inhibiting
the limited proteasome capacity in cells, then misfolded
CFTR should have the reciprocal effect on hook2, which
was not observed (Fig. 2). Together, these data argue
against hook2 enhancing aggresome formation solely by
acting as a misfolded substrate for aggresomes.
Instead, hook2 may act on the dynein-mediated retro-
grade transport of aggresome components. Aggresome
formation depends on retrograde transport of misfolded
protein aggregates and other aggresome components by
cytoplasmic dynein, since nocadozole-induced depolym-
erization and dynamitin expression interfere with aggre-
some formation [4,16]. As a consequence of changes in
microtubule dependent transport, dynein itself can accu-
mulate in aggresomes [Fig. 1I, J and ref. [16]]. Thus, the
inhibitory effect of truncated hook2 proteins on aggre-
some formation may, at least in part, reflect their disrup-
tive effects on the radial array of microtubules [21].
Support for a model in which hook2 participates in the
dynein-mediated retrograde transport of aggresome com-
ponents comes from observations of its distant C. elegans
homolog zyg-12. In early C. elegans embryos, zyg-12 is
necessary for the positioning of centrosomes close to
nuclei [24], a process that requires the recruitment of
dynein and the dynein-associated proteins lis-1 and arp-1
to the nuclear membrane [24]. Two-hybrid analysis has
suggested a direct interaction between zyg-12 and the
dynein light intermediate subunit [24]. However, our
attempts to demonstrate a direct interaction between
hook2 and cytoplasmic dynein have not been successful
and we did not notice significant co-localization of hook2
with peripheral CFTR aggregates. Alternatively, hook pro-
teins may indirectly participate in retrograde transport by
functioning as transient linker proteins or attachment fac-
tors during the loading of cargo onto the dynein/dynactin
complex [18,27,29]. Such linker proteins may also con-
tribute to the anchoring and stabilization of microtubules
[29], functions traditionally attributed to centrosomes.
Consistent with such a role of centrosomal hook2, domi-
nant-negative hook2 constructs interfered with the
regrowth of microtubules after their nocodazole-induced
depolymerization [21]. In this context, it is also interest-
ing to notice that the two hook2/3 chimeras that pro-
moted aggresome formation in the absence of lactacystin
(Fig. 3A) were previously found to localize to centrosomes
[21].
A possible function of hook2 in modulating the retro-
grade transport of non-membranous protein particles is in
line with observations that implicated other members of
the hook family in modulating the movement and
anchoring of organelles. Interference with hook3 function
causes the dispersal of the Golgi complex [20], similar to
the effect of overexpression of the dynamitin subunit of
the dynein/dynactin complex [30,31]. Furthermore,
hook1 is abundant in differentiating murine spermatids
where it localizes to the ends of the microtubule man-
chette at the time of flagellar development. A deletion in
the hook1 gene underlies the mouse mutation abnormal
spermatozoon head shape (azh). Azh males have reduced fer-
tility, a phenotype that correlates with malpositioning of
the manchette, abnormal shaping of the spermatid
nucleus, and fragile sperm tails [32]. The displacement of
the manchette, a spermatid-specific microtubule array in
azh mice [32] is consistent with an involvement of hook1
in the anchoring of microtubules.
These observations in azh mutant mice lacking hook1 and
our finding that hook2 localizes to centrosomes, at least
in part through a direct interaction with centriolin [21],
suggest an alternative model in which the effects of hook
proteins on transport are mediated through directly alter-
ing the functioning of the centrosome. One major role ofBMC Cell Biology 2007, 8:19 http://www.biomedcentral.com/1471-2121/8/19
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centrosomes is to support the nucleation and organiza-
tion of microtubules [33,34] and thus ultimately to con-
trol vectorial protein transport. In a previous study, we
could not detect an effect of hook2 on microtubule nucle-
ation but our data revealed a contribution of hook2 to the
maintenance of the radial arrangement of microtubules
[21]. However, since cytoplasmic dynein also transports
centrosomal proteins and microtubules [35-37], it is not
straightforward to distinguish direct effects on centro-
somes from the indirect consequences of abnormal retro-
grade transport. Future studies to unravel the molecular
mechanisms by which hook2 contributes to the forma-
tion of aggresomes should take into consideration that
hook2 may modulate microtubule-dependent retrograde
transport.
Conclusion
Taken together with previous findings that hook2 local-
izes to centrosomes, binds directly to centriolin and that
interference with hook2 function disturbs the radial
organization of microtubules, our results indicate that
centrosomally localized hook2 promotes the generation
or maintenance of aggresomes when misfolded proteins
accumulate in cells. Based on the functions observed for
other hook homologs [20,24,32] and the defects in the
radial organization of microtubules upon interference
with hook2 function [21], we propose that hook2 func-
tion is required for the microtubule-based delivery of pro-
tein aggregates to pericentriolar aggresomes.
Methods
Cell lines
The following cell lines were used in this study, with tissue
and species source for each line in parenthesis: HEK 293
(human embryonic kidney), VERO (adult African green
monkey kidney); these cell lines were obtained from
ATCC (American Type Culture Collection; Manassas, VA)
and maintained as recommended by ATCC.
Sources of Antibodies
Polyclonal antibodies against hook2 (aa 427–719) and
hook3 (423–630) have been described [20]; these were
diluted 1:200–1:400 to detect endogenous hooks and
1:400–1:600 to detect overexpressed hooks by immuno-
histochemistry and 1:2,000–1:10,000 for immunoblot-
ting. Anti-tubulin, dynein 74.1, anti-heat shock protein
70 and rabbit ubiquitin antibodies were from Sigma
(Saint Louis, MO; sigma-aldrich.com); GM130 from BD
Transduction Labs (bdbiosciences.com); FK1, anti-ubiq-
uitin, and anti-20S proteasome antibodies from Biomol
International (biomol.com); mouse anti-CFTR
(mAb3A7) or mouse anti-human CFTR (C-24-1) at 1:150
for immunostaining and immunoprecipitation, 1:1000
for immunoblotting (Research Diagnostics, Inc.; Flers,
NJ). Secondary antibodies for immunoblots were horse-
radish peroxidase labeled goat anti-mouse and anti-rabbit
from Bio-Rad, each used at a dilution of 1:10,000. Sec-
ondary antibodies for immunofluorescence were Alexa-
488, -564, or -594 conjugated goat anti-mouse or goat
anti-rabbit antibodies from Molecular Probes (Eugene,
OR), each used at a dilution of 1:400.
Immunoblotting and immunoprecipitation
Equal amounts of cell extracts, or cell homogenates were
separated by SDS-PAGE gels (Criterion Precast Gels; Bio-
Rad; Hercules, CA) and transferred to nitrocellulose (Sch-
leicher and Schuell; Keene, NH). Prior to the application
of antibodies, membranes were blocked in 3% non-fat dry
milk in wash buffer (20 mM Tris-HCl pH 7.5; 150 mM
NaCl; 1% Tween-20) for 1 h at RT or over-night at 4°C.
Primary antibodies were applied in block for 1–2 hrs at
RT. Secondary antibodies (goat anti-mouse or anti-rabbit
IgG-HRP conjugate (Bio-Rad) were diluted 1:10,000 and
applied for 1 hour at RT. Blots were rinsed at least three
times in wash buffer. Immunoreactive bands were visual-
ized on Blue Biofilm (Denville Scientific; Metuchen, NJ)
after the application of SuperSignal West Pico Stable or
West Femto Stable ECL substrate (Pierce; Rockford, IL).
Finally, the efficiency of protein transfer to blots was
assessed by staining membranes with the MemCode pro-
tein stain (Pierce; Rockford, IL). Immunoprecipitation of
CFTR followed the protocol described by Ward et al.
(1995).
cDNA constructs and transfections
Constructs expressing various hook2 and hook3 wild-type
or mutant proteins have been described [20,21]. In brief,
the constructs 223, 322, 332, 233, 323, and 232 are chi-
meras of hook2 and hook3: 223 contains hook2 aa 1–567
and hook3 aa 573–719; 322 contains hook3 aa 1–213
and hook2 aa 210–719; 332 contains hook3 aa 1–572
and hook3 aa 567–719; 233 contains hook2 aa 1–210
and hook3 aa 215–719; 323 is hook3 with a hook2 insert
from aa 213 to 572; 232 is hook2 with a hook3 insert
from aa 210 to 567. Chimeras were designed to approxi-
mate locations of the previously mapped N-terminal
microtubule binding region, the central coiled-coil
homodimerization domain, and the proposed organelle
binding C-terminal domain boundaries [20-22]. ∆C-
hook2, ∆N-hook2 and ∆Cl-hook2 are deletion constructs
of hook2: from ∆C-hook2 aa 533–719 were deleted, from
∆N-hook2 aa 1–161, and from ∆Cl-hook2 aa 439–554,
including 507–548 that comprises the C-terminal region
of the coil-coil domain. Each of the constructs was
inserted into mammalian expression vector pcDNA3.1
that contains a CMV promoter (Invitrogen, Carlsbad, CA;
invitrogen.com). Plasmids pCMVNot6.2 and
pCMVNot6.2-∆F508 containing expressible human CFTR
cDNAs were the generous gift of Dr. Johanna Rommens
(The Hospital For Sick Children, Toronto). A constructBMC Cell Biology 2007, 8:19 http://www.biomedcentral.com/1471-2121/8/19
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expressing a GFP-tagged CFTR [38] was a gift of Bruce
Stanton (Dartmouth Medical School).
Vero and HEK cells were transfected with Fugene (Roche;
Indianapolis, IN) using a ratio of 1 µg DNA per 3 µl
Fugene for HEK cells and a 1:6 ratio for Vero cells.
Differential detergent extraction of live cells and 
preparation of whole cell lysates
Vero cells grown on 35–60 mm plates were placed on a
slide warmer and rinsed several times with 37°C PHEM
buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, and
1 mM MgCl2, pH 7.4). Cells were sequentially extracted
for 3 min with increasing concentrations of detergents
(0.1% and 1% Triton X-100 and finally 1% SDS) in 100–
300 µl PHEM buffer containing protease inhibitors for
mammalian cells (Roche; Indianapolis, IN). Each fraction
was centrifuged at 20,000 × g and supernatants of each
fraction and in some cases the pellet of the 1% SDS frac-
tion were further solubilized in loading buffer with 6%
SDS prior to loading. Whole-cell lysates were obtained by
scraping cells directly into loading buffer after washes in
serum-free medium at 37°C.
Immunocytochemistry and microscopy
For immunohistochemistry, cells grown on 4-well Lab-
Tek II chamber slides (Nalgene-Nunc) up to a density of
~5000 cells/cm2 were rinsed with PHEM buffer at 37°C,
then fixed in methanol at -20°C for 8 min. After two
rinses with PBS, formaldehyde-fixed cells were permeabi-
lized in 0.2% Triton X-100 in PBS for 10 min at room tem-
perature. Nonspecific binding was blocked with 2.5%
gelatin/3% BSA/0.2 Triton X-100 in PBS pH 7.4 for at least
45 min at 37°C. Antibodies were diluted in blocking solu-
tion; primary antibodies were applied overnight at 4°C
and secondary antibodies for 1 hr at room temperature.
Washes were in 0.2% Tween-20 in PBS. Nuclei were
stained with 0.5 µg/ml Hoechst (Aldrich Chemicals, St.
Louis, MO). After rinses in 50 mM Tris (pH 8.0), sections
were mounted with Gel/Mount (Biomedia, Foster City,
CA).
Fluorescent cell preparations were viewed through 20×
(NA 0.5), 40× (NA 1.0) or 100× (NA. 1.3) PL/Fluotar
Leica objectives on a Leica Leitz, DMR microscope
(Thornwood, NY). Images were captured with an Axio-
Cam camera (Zeiss) controlled by Axiovision 3.0. All
images used for determining the co-localization of pro-
teins were captured in sequential mode with a Leica CS
SP2 confocal scanner on a Leica DMIRE2 microscope
through a 63× HCX PL APO (NA1.32) objective. Images
were assembled into panels in Adobe Photoshop (Adobe
Systems, Mountain View, CA) and all images within a
panel were adjusted together for contrast and brightness.
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